 AdvanSix Inc NYSE: ASIX reported third-quarter FY21 sales growth of 58 year-over-year to 446.49 million, beating the consensus of 408.15 million. Sales volume in the quarter increased 8, driven by improved end-market demand across ammonium sulfate, nylon and caprolactam product lines. 